Notes to Editors About Abcam plc As an innovator in reagents and tools, Abcam s purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, the Company offers highly validated biological binders and assays to address important targets in critical biological pathways. Already a pioneer in data sharing and ecommerce in the life sciences, Abcam s ambition is to be the most influential company in life sciences by helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. Two-thirds of the world s 750,000 life science researchers use Abcam s affinity binders, reagents, biomarkers and assays and the Company s products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences.
Investegate |ABCAM PLC Announcements | ABCAM PLC: Interim Results for 6 months ended 31 Dec 2020
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Notes to Editors About Abcam plc As an innovator in reagents and tools, Abcam s purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, the Company offers highly validated biological binders and assays to address important targets in critical biological pathways. Already a pioneer in data sharing and ecommerce in the life sciences, Abcam s ambition is to be the most influential company in life sciences by helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. Two-thirds of the world s 750,000 life science researchers use Abcam s affinity binders, reagents, biomarkers and assays and the Company s products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Abcam Plc Appointment of Non-Executive Directors
AbcamJanuary 28, 2021 GMT
CAMBRIDGE, United Kingdom, Jan. 28, 2021 (GLOBE NEWSWIRE) Abcam plc (AIM: ABC; Nasdaq: ABCM) (“Abcam”), a global leader in the supply of life science research tools, is delighted to announce the appointments of Bessie Lee and Mark Capone as non-executive Directors with immediate effect.
Both Bessie and Mark bring extensive and complementary executive and non-executive experience to the Board of Abcam.
Based in China, Bessie Lee is the Chief Executive Officer of Withinlink, a China-based venture capital firm and start-up incubator focused on marketing technology, which she founded in 2015. Prior to founding Withinlink, Bessie spent almost three decades at WPP plc, holding Chief Executive Officer roles in China for Mindshare, GroupM and finally WPP. Bessie is currently a non-executive Director of Electrocom
Abcam returns to growth in first half with over 8% increase in constant currency revenue 11 January, 2021, Cambridge, UK - Abcam plc (AIM: ABC; Nasdaq: ABCM) ( Abcam ), a global leader in the supply of life science research tools , announces the following unaudited trading update ahead of reporting its results on 8 March 2021 for the six months ended 31 December 2020. Overall, we expect to report total first half revenue of £147.5 million (H1 2020: £138.2 million), representing growth of 8.3% on a constant currency basis and 6.7% on a reported basis. In-house products represented over 55% of total revenue and grew by over 25%. On a constant currency basis, catalogue revenue, representing 95% of the total, grew approximately 8.0% in the half whilst CP&L
vimarsana © 2020. All Rights Reserved.